What Is a Retinal Vein Occlusion?

​

A retinal vein occlusion (RVO) occurs when a vein responsible for draining blood from the retina becomes blocked. This interruption in blood flow can lead to bleeding, retinal swelling, and vision changes.

​

The retina depends on healthy circulation to function properly. When a retinal vein becomes obstructed, fluid and blood may leak into the retina, sometimes causing swelling in the macula, known as macular edema.

​

There are two primary types of retinal vein occlusions:

​

• Branch Retinal Vein Occlusion (BRVO):
  A blockage affecting one of the smaller retinal vein branches.

• Central Retinal Vein Occlusion (CRVO):
  A blockage involving the main retinal vein, which may affect a larger portion of the retina.

​

RVO is often associated with conditions such as high blood pressure, diabetes, high cholesterol, and cardiovascular disease.

​

Common Symptoms

​

Symptoms of retinal vein occlusion may include:

​

• Sudden or gradual blurred vision

• Distorted vision

• Dark spots or floaters

• Areas of missing vision

• Reduced sharpness or clarity of vision

• Vision loss affecting one eye

​

The severity of symptoms can vary depending on the location and extent of the blockage.

​

Why Clinical Trials Matter

​

Clinical trials for retinal vein occlusions help researchers evaluate new therapies and treatment strategies aimed at reducing retinal swelling, improving vision outcomes, and better managing retinal vascular disease.

​

Research studies may investigate investigational medications, longer-acting therapies, imaging technologies, or emerging approaches for treating BRVO, CRVO, and associated macular edema. Participation in clinical research contributes to ongoing efforts to improve future care options for patients living with retinal vascular conditions.

​

Each clinical trial has specific eligibility requirements, and participation is always voluntary.